PFG Investments LLC Has $6.37 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

PFG Investments LLC boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 113.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,872 shares of the healthcare conglomerate's stock after acquiring an additional 6,830 shares during the quarter. PFG Investments LLC's holdings in UnitedHealth Group were worth $6,368,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Norges Bank bought a new position in UnitedHealth Group in the fourth quarter valued at about $5,802,231,000. International Assets Investment Management LLC grew its position in shares of UnitedHealth Group by 53,573.1% during the 4th quarter. International Assets Investment Management LLC now owns 2,352,490 shares of the healthcare conglomerate's stock worth $1,238,515,000 after buying an additional 2,348,107 shares during the period. Jennison Associates LLC grew its position in shares of UnitedHealth Group by 49.3% during the 4th quarter. Jennison Associates LLC now owns 3,617,813 shares of the healthcare conglomerate's stock worth $1,904,670,000 after buying an additional 1,195,352 shares during the period. Mawer Investment Management Ltd. grew its position in shares of UnitedHealth Group by 75.0% in the 3rd quarter. Mawer Investment Management Ltd. now owns 2,011,150 shares of the healthcare conglomerate's stock valued at $1,014,002,000 after purchasing an additional 862,024 shares during the period. Finally, California Public Employees Retirement System grew its position in shares of UnitedHealth Group by 35.9% in the 4th quarter. California Public Employees Retirement System now owns 3,090,986 shares of the healthcare conglomerate's stock valued at $1,627,311,000 after purchasing an additional 815,822 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the firm's stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm's stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company's stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Stock Performance

NYSE UNH traded up $1.49 on Friday, reaching $495.35. The stock had a trading volume of 2,727,016 shares, compared to its average volume of 5,623,667. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.85 and a quick ratio of 0.79. The firm has a fifty day moving average of $485.84 and a two-hundred day moving average of $514.14. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $554.70. The company has a market cap of $455.76 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.43 and a beta of 0.54.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts' consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The company's revenue for the quarter was up 8.6% on a year-over-year basis. During the same period in the prior year, the firm posted $6.26 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group's dividend payout ratio (DPR) is presently 45.97%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Cantor Fitzgerald reiterated an "overweight" rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, April 10th. HSBC upgraded UnitedHealth Group from a "reduce" rating to a "hold" rating and set a $460.00 target price on the stock in a research note on Thursday, April 4th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the company a "buy" rating in a research note on Friday, April 19th. Bank of America restated a "buy" rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Finally, Wells Fargo & Company cut their target price on UnitedHealth Group from $600.00 to $525.00 and set an "overweight" rating on the stock in a research note on Monday, April 8th. Four investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $570.05.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.